- Home
- / Envoy Medical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Envoy Medical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$2.5
2024-10-29
Market Capitalization
$50.9 M
2024-10-29
Revenue
$241 K
FY, 2025
CreditSafe Score
?
Score changed on Jun 14, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|
| Revenue | 316.0K | 225.0K | 241.0K | ||
| Cost of goods sold | 789.0K | 742.0K | 874.0K | ||
| Gross profit | (517.0K) | (633.0K) | |||
| Gross profit margin, % | -229.8% | -262.7% | |||
| General and administrative expense | 7.3M | 6.8M | 7.9M | ||
| Operating expense total | 17.9M | 18.7M | 21.6M | ||
| EBIT | (5.2M) | (4.9M) | (18.4M) | (19.3M) | (22.3M) |
| EBIT margin, % | -8558.2% | -9240.7% | |||
| Interest income | 37.7K | 6.1M | |||
| Interest expense | 41.0K | 36.0K | |||
| Pre tax profit | 20.7M | (23.8M) | |||
| Income tax expense | 1.5M | 5.8M | 2.6M | ||
| Net Income | (251.6K) | 19.2M | (29.9M) | (20.8M) | (23.8M) |
| EPS | (2.0) | (1.5) | (1.2) |